High-purity human Factor VIII / von Willebrand Factor (VWF) concentrate for prophylaxis and treatment of bleeding in patients with haemophilia A. Octanate undergoes two independent virus-inactivation steps (solvent/detergent treatment and terminal dry heat for 30 minutes at 100°C).
Octanate naturally stabilised with VWF, every FVIII is bound to and protected by VWF due to the multiple FVIII-binding sites in each VWF molecule.
Available in vials of:
- 250 IU
- 500 IU
- 1000 IU
